Home
James B. Breitmeyer, CEO: Oncternal Therapeutics ONCT Buy · Filed 23/04/17
Trade details
- Type
- Insider buy
- Amount
- $652.5
- Shares · price
- 2,250 sh · $0.29 a share
- Held after
- 196,544 sh
- Person
- James B. BreitmeyerCEO
- Trade date
- 23/04/14
- Filed
- 23/04/17
- Days to filing
- 3 days
4 insiders bought this week
- Insiders buying this week
- 4 insiders
- Holding change
- +1.2%
Oncternal Therapeutics trades, last 26 weeks
What else happened in Oncternal Therapeutics around then
Filed or reported within 30 days of the trade day · 23/03/15~23/05/14James B. Breitmeyer's recent trades
- James B. Breitmeyer
BuyOncternal Therapeutics
BuyOncternal Therapeutics
ONCT
$29K
100,000 sh
$29K
Filed 23/04/17
Traded 23/04/13
- James B. Breitmeyer
BuyOncternal Therapeutics
BuyOncternal Therapeutics
ONCT
$14.3K
47,750 sh
$14.3K
Filed 23/04/17
Traded 23/04/14